Evidence map›Paper›PMID 39229279›Full record

ArticleFrontiers in immunology2024

Regulation of

Chandani Mitchell, Shanieka Staley, Michal Claire Williams, Archana Saxena, Raymond Bogdon, Kasie Roark, Michele Hailey, Kathryn Miranda, William Becker, Nicholas Dopkins and 7 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Chandani MitchellDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Shanieka StaleyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Michal Claire WilliamsDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Archana SaxenaDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Raymond BogdonDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Kasie RoarkDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Michele HaileyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Kathryn MirandaDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
William BeckerDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Nicholas DopkinsDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Maria Marjorette PenaDepartment of Biological Sciences, College of Arts and Sciences, University of South Carolina, Columbia, SC, United States.
Kristen M HoganDepartment of Biological Sciences, College of Arts and Sciences, University of South Carolina, Columbia, SC, United States.
Maredith BairdDepartment of Biological Sciences, College of Arts and Sciences, University of South Carolina, Columbia, SC, United States.
Kiesha WilsonDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Prakash NagarkattiDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Mitzi NagarkattiDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Philip Brandon BusbeeDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.

Funding

Role of the environmental sensor, AhR on colitisR01AI160896 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2021 to 2025
$2.6M
Epigenetic mechanisms in Transgenerational Effects of an Environmental PollutantR01ES030144 · NIEHS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2019 to 2023
$2.5M
Role of Macrophages in CBD mediated attenuation of SEB-induced ARDSR00GM147910 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI WILSON, KIESHA · 2023 to 2025
$747k
NIAID NIH HHS R01 AI160896NIEHS NIH HHS R01 ES030144NIGMS NIH HHS R00 GM147910
6 · The paper itself

Abstract

Introduction: Colitis is an inflammatory bowel disease (IBD) characterized by immune cell dysregulation and alterations in the gut microbiome. In our previous report, we showed a natural product in cruciferous vegetables and ligand of the aryl hydrocarbon receptor (AhR), indole-3-carbinol (I3C), was able to reduce colitis-induced disease severity and microbial dysbiosis in an interleukin-22 (IL-22) dependent manner. Methods: In the current study, we performed single-cell RNA sequencing (scRNAseq) from colonocytes during colitis induction and supplementation with I3C and show how this treatment alters expression of genes involved in IL-22 signaling. To further define the role of IL-22 signaling in I3C-mediated protection during colitis and disease-associated microbial dysbiosis, we generated mice with AhR deficiency in RAR-related orphan receptor c (Rorc)-expressing cells (AhR Results: Results showed AhR Discussion: Collectively, this report highlights the cell and sex-specific role of AhR in regulating microbes that can impact colitis disease.

Indexed as

BacteroidesColitisInterleukin-22InterleukinsReceptors, Aryl HydrocarbonAnimalsBasic Helix-Loop-Helix ProteinsDisease Models, AnimalDysbiosisFemaleGastrointestinal MicrobiomeIndolesMaleMiceMice, Inbred C57BLMice, KnockoutAhr protein, mouseBasic Helix-Loop-Helix Proteinsindole-3-carbinolIndolesInterleukin-22InterleukinsReceptors, Aryl Hydrocarbonaryl hydrocarbon receptorbacteroides acidifacienscolitisindole-3-carbinolinflammatory bowel diseaseinnate lymphoid type 3 cellsinterleukin-22sex differences

Identifiers

PMID39229279
PMCPMC11368719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.